Gonorrhea and Chlamydia

Slides:



Advertisements
Similar presentations
Recommendations for STD Clinical Preventive Services for Persons Living with HIV/AIDS.
Advertisements

S L I D E 0 Sexually Transmitted Infections in adolescents Deepa Camenga, MD, MHS, FAAP Instructor of pediatrics, adolescent medicine Yale School of Medicine.
URETHRAL DISCHARGE Treat for Gonorrhoea and Chlamydia 4 Cs:
Antimicrobial Resistance in N. gonorrhoeae A Review
Kingdom of Bahrain Ministry of Health ( Syndromic Mangement ) Adopted from : IPPF MEDICAL AND SERVICE DELIVERY GUIDELINES FOR SEXUAL AND REPRODUCTIVE HEALTH.
Antimicrobial Resistance in N. gonorrhoeae – An Overview 2014 INTRODUCTION Progressive antimicrobial resistance in Neisseria gonorrhoeae is an emerging.
Pelvic inflammatory disease
Pelvic Inflammatory Disease. Does LEEP increase the risk of PTB before 37 weeks? Compared women with history of LEEP to Compared women with history of.
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
Challenges to IPP: Emerging Gonococcal Antimicrobial Resistance and Skepticism That Screening in Its Current Form Can Reduce Chlamydial Morbidity Edward.
Chlamydia trachomatis
STD Surveillance 2001 Adapted from CDC by Jill Gallin, CPNP Assistant Professor of Clinical Nursing.
2014 PATIENT HISTORY How would you diagnose and screen Miranda? How would you treat Miranda? Are there any additional steps you would take? Antimicrobial.
Gonococcal Isolate Surveillance Project (GISP)
Pelvic Inflammatory Disease (PID)
Pelvic Inflammatory Disease (PID) Natasha Lomax Tamika Missouri Monique Veney.
Neisseria gonorrhoeae (Gonococcus)  N. gonorrhoeae causes the sexually transmitted disease gonorrhoea.  The gonococcus was first described by Neisser.
Kees Rietmeijer, MD, PhD Denver Prevention Training Center 1.
Chlamydia trachomatis testing Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is Chlamydia trachomatis? Chlamydia.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 94 Drug Therapy of Sexually Transmitted Diseases.
Denver Prevention Training Center Denver Public Health Department Pieces of the Puzzle Conference Great Falls November 21, 2013.
Sexually Transmitted Diseases I
Chlamydial and Gonococcal Infections. An STD About to Happen!
Have You Heard About the New Bug Around Town?
Alice Beckholt RN, MS, CNS
STD 2014.
Sexually Transmitted Diseases: Genital Syndromes in Men
Faiza Ali MD, Ericka Hayes MD, Gaurav Kaushik MPH, Nicole Carr RN, Katie Plax MD Washington University School Of Medicine Department of Pediatrics.
Sexually transmissible infections Dr Ursula Nusgen SpR in Microbiology St. James’s Hospital.
Rapid Emergence of Gonococcal Fluoroquinolone Resistance in Men Who Have Sex with Men in King County, WA WLH Whittington MR Golden KK Winterscheid SA Wang.
Sexually Transmitted Diseases Part 2
Epidemiology Lab. Cup #____--Data Table 1-My partners 123 INFECTED PERSONS123 Data table 2- Classmate’s partners Bellringer- Copy these tables on page14.
PID Normal Human Fallopian Tube Tissue C. trachomatis Infection (PID)
Katie DePlatchett, M.D. AM Report January 4 th, 2010.
Reproductive block Dr.Malak El-Hazmi Objectives Name various etiological agents causing STD. Describe the clinical presentations of STD. Discuss.
UTIs (Cystitis) Fluoroquinolones, TMP/SMX, nitrofurantoin, amoxicillin- clavulanate, cephalosporins, tetracyclines, and fosfomycin. Most women: 3 days.
A Man with Penile Ulcerations The 5-Minute STI Clinical Case Study.
Reproductive block Objectives Name various etiological agents causing sexually transmitted diseases (STD) Describe the clinical presentations.
بسم الله الرحمن الرحيم FAMILY: NEISSERIACEAE Prof. Khalifa Sifaw Ghenghesh.
FIGURE 1. URETHRAL DISCHARGE. Treatment of Urethral Discharge GonorrheaChlamydia Ciprofloxacin 500mg orally x 1 doseAzithromycin 1g orally x 1 dose Cefixime.
Impetigo The best topical agent is mupirocin; other agents, such as bacitracin and neomycin, are less effective. Patients who have numerous lesions or.
By: Hayley MacDonald and Morgan Dolak
Sexullay transmitted diseases
CASE 2 THE MICROBIOLOGY LABORATORY Ashley Wang, Feb
Urethritis and Genital Discharge
Neisseria.  Aerobic  Gram-negative cocci often arranged in pairs (diplococci)  Oxidase positive  Most catalase positive  Nonmotile General Characteristics.
STD SCIENCE FAIR CHLAMYDIA By:David Robinson. CAUSE OF THE DISEASE Chlamydia is caused by the bacteria chlamydia trachomatis.
Drug Therapy of Sexually Transmitted Diseases. Sexually Transmitted Diseases  Sexually transmitted diseases (STDs)  Infections or parasitic diseases.
 Sexually transmitted diseases (STDs) are the venereal disorders that are caused by a variety of pathogenic microorganisms.  In almost all the countries.
CHLAMYDIA TRACHOMATIS – DIAGNOSIS AND MANAGEMENT Jess Gaddie (adapted from presentation by Rachel Coyne)
Mayuri Dasari M.D. Cook County Loyola Provident
Gonorrhea Testing, Diagnosis and Treatment
MICROBIOLOGY PRACTICAL
Dx: samples from endocx (columnar epith.)
SEXUALLY TRANSIMITTED DISEASES BY
Topic Gonorrhea Diseases
Gonorrhoea & PID PHCP 402 By K S Labaran.
A qPCR assay that simultaneously detects Mycoplasma genitalium and mutations associated with macrolide resistance Litty Tan Director of Research & Development.
Mycoplasma & Chlamydia
Gonococcal Isolate Surveillance Project (GISP)
Urethritis in males.
Pelvic Inflammatory Disease (PID)
Chlamydial and Gonococcal Infections
Non-Viral STD of Major significance
Pelvic Inflammatory Disease (PID)
Current STD Testing and Treatment Guidelines
Gonorrhea Epidemiology and Control Efforts in Louisiana
A decade of multi-drug resistant N. gonorrhoea in Coventry, UK
Management of Gonorrhea and Chlamydia in Patients with HIV
Presentation transcript:

Gonorrhea and Chlamydia David H. Martin, MD LSU Health Sciences Center Section of Infectious Diseases

Disclosure I have no financial interests or other relationship with manufacturers of commercial products, suppliers of commercial services, or commercial supporters. My presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

An STD About to Happen!

Cell Monolayer Infected with Chlamydia and Stained with Chlamydia Specific Fluorescent Antibodies Cell cytoplasma counter stained red Chlamydial inclusions stained apple green

Electron Micrograph of a Chlamydia Infected Endocervix Columnar epithelial cells Chlamydial inclusion Microabscess

Male GU tract

Gonococcal Urethritis

Gram Negative Intracellular Diplococci (GNID)

Nongonococcal Urethritis

Inflammation Without GNID

Etiology of Nongonococcal Urethritis - 2002 Chlamydia trachomatis 20-40% Ureaplasma urealyticum 20-40% ? Mycoplasma genitalium 20-25% Trichomonas vaginalis 1-5% Herpes simplex virus <1%

Epidydimitis Scrotal erythema Discharge

Gonococcal Endocervicitis

Chlamydial Endocervicitis

Etiology of PID 1. N. gonorrhoeae 20-40% 2. C. trachomatis 20% 3. Mixed aerobes and anaerobes including Mycooplama hominis + N. gonorrhoeae 40-60%

Diagnosis of PID History Lower abdominal pain of less than 15 days duration Constant pain Onset within 7 days of menstruation Fever and/or chills Sexual history

Diagnosis of PID Signs Bilateral adnexal tenderness Cervical motion pain Adnexal mass Endocervical discharge IUD

Maternal Chlamydial Infection 65% of infants are infected 5% of infants develop pneumonia 30 – 50% of infants develop conjunctivitis

Proportion of Chlamydial and Gonococcal Infections that are Asymptomatic Women Men C. trachomatis 80-90% 70-80% N. gonorrhoeae 50-70% 20-30%

Epidemiology

U.S. Gonorrhea Rates: 1970–2000

Chlamydia — Trends in positivity among 15-44 year old women tested in family planning clinics, 1988–2000

Diagnosis

Gram Negative Intracellular Diplococci (GNID)

One Step Methylene Blue Stain

Performance of Culture for N. gonorrhoeae and C. trachomatis *Assuming no mistakes are made in specimen labeling and laboratory procedures.

Cell Monolayer Infected with Chlamydia and Stained with Chlamydia Specific Fluorescent Antibodies Cell cytoplasma counter stained red Chlamydial inclusions stained apple green

Performance of the Pace 2 Gonococcal DNA Hybridization Assay in Women Sensitivity Specificity Range of 10 studies 85-100% 96-99% Mean 92.1% 98.3%

A Systematic Review of NAAT Sensitivity Using Urine, Cervical and Urethral Specimens for Chlamydial Infections Assay Type Women Men Urine Cervix Urethra PCR 83% 86% 84% 88% TMA 92% 99% 96% SDA 80% 93% PCR-polymerase chain reaction. TMA-transcription mediated amplification. SDA-strand displacement amplification. Cook RL, et al. Annals Int Med. 2005; 142: 914

Performance of an Amplification Test for the Detection of N Performance of an Amplification Test for the Detection of N. gonorrhoeae in Endocervical, Male Urethra and Urine Specimens *True positive defined as positive endocervical or urethral culture or LCR and alternative gene target positive by LCR Koumans EH, et al. Clin Infect Dis 1998;27:1171.

Potential Urine Based Screening Opportunities Juvenile detention/jails Emergency departments High schools General medicine clinics, especially teen clinics Drug rehabilitation programs Homeless clinics Military induction centers

Vaginal Swab Study Specimen Collection Illustration Take the swab out of the sealed package 1 Remove the swab and hold it in the middle of the plastic handle 2 Carefully put the swab about two inches inside the opening of your vagina and gently turn the swab for 20 seconds. Make sure the swab touches the walls of your vagina 3 Remove the cap from the tube and put the swab into the tube so that you can see the tip is below the label 4 Carefully break the plastic handle against the side of the tube 5 Tightly screw the cap onto the tube. Follow the packaging instructions and mail the specimen 6

Sensitivity of Different Specimens by Three Different Assays FCU Cx S-vag C-vag TMA 72% 89% 93% 90% PCR 84% 91% LCR 98% 96% 100% Combined 81% FCU – first catch urine, Cx – endocervix, S-vag – self-collected vaginal swab, C-vag - Clinician collected vaginal swab. Schachter J, et al. STD 32;2005:725

Testing Preference Survey Among 1090 Women Following a Pelvic Examination and a SOVs Protocol 90% found self collection of vaginal swabs very easy and another 7% found it somewhat easy. 76% preferred a SOVs over a pelvic examination. 60% preferred it over a urine specimen. 94% said they would be tested for STIs more often is SOVs were available. Chernesky MA, et al. Sex Transm Dis 32; 2005:729

Penicillin and Tetracycline Resistance Among U. S Penicillin and Tetracycline Resistance Among U.S. Gonococcal Isolates- 2000

2006 CDC STD Treatment Guidelines Uncomplicated Gonococcal Infections Recommended Regimens Cefixime 400 mg orally in a single dose or Ceftriaxone 125 mg IM in a single dose Ciprofloxacin 500 mg orally in a single dose Levofloxacin 250 mg orally in a single dose PLUS (If chlamydia not ruled out) Doxycycline 100 mg orally 2 times a day for 7 days or Azithromycin 1 gm orally

Percent of U.S. N. gonorrhoeae Isolates With Decreased Susceptibility or Resistance to Ciprofloxacin, 1990–2000

2006 CDC STD Treatment Guidelines Uncomplicated Gonococcal Infections Alternative Regimens Spectinomycin 2 g IM single dose Other single dose IM Cephalosporins (cefotaxime 500 mg, cefoxitin 2 g + probenecid, etc.) Other single dose Quinolones (enoxacin 400 mg, lomefloxacin 400 mg, norfloxacin 800 mg)

2006 CDC STD Treatment Guidelines Chlamydial Infections Recommended Regimens Azithromycin 1 gram, orally, single dose Doxycycline 100 mg orally 2 times a day for 7 days

2006 CDC STD Treatment Guidelines Nongonococcal Urethritis (NGU) Recommended Regimens Azithromycin 1 gram, orally, single dose Doxycycline 100 mg orally 2 times a day for 7 days

2006 CDC STD Treatment Guidelines Persistent or Recurrent NGU Metronidazole 2 grams, orally, single dose OR Tinidazole 2 grams, orally, single dos PLUS Azithromycin 1 gram, orally, single dose (if not used previously)

2006 CDC STD Treatment Guidelines Chlamydial Infection During Pregnancy Recommended Regimens Azithromycin 1 gram, orally, single dose OR Amoxicillin 500 mg orally 3 times daily for 7 days

2006 CDC STD Treatment Guidelines Mild PID Recommended Regimen B Ceftriaxone 250 mg IM once PLUS Doxycycline 100 mg orally 2 times a day for 14 days WITH OR WITHOUT Metronidazole 500 orally 2 times daily for 14 days

Just a little sunshine…

Just a little rain…

Just a little pleasure…

AND THEN….

Just a little PAIN!!